The FANCD2 Gene encodes a protein involved in critical cellular processes related to DNA repair and genomic stability. This gene has been studied in the context of neurodegenerative diseases including Parkinson's disease and ALS, as well as various cancer predisposition syndromes. [@taniguchi2002]
The FANCD2 Gene encodes a protein involved in critical cellular processes related to DNA repair and genomic stability. This gene has been studied in the context of neurodegenerative diseases including Parkinson's disease and ALS, as well as various cancer predisposition syndromes. [@taniguchi2002]
FANCD2 (Fanconi Anemia Group D2) encodes a key protein in the Fanconi anemia (FA) DNA repair pathway, which is essential for resolving DNA interstrand crosslinks (ICLs) and maintaining genomic stability. The FA pathway works collaboratively with nucleotide excision repair (NER) and homologous recombination (HR) to protect cells from DNA damage. FANCD2 has emerged as an important link between DNA repair defects and neurodegenerative diseases, particularly Parkinson's disease and ALS.
Function
FANCD2 is a key protein in the Fanconi anemia (FA) DNA repair pathway, which is essential for resolving DNA interstrand crosslinks (ICLs). The FA pathway works collaboratively with nucleotide excision repair (NER) and homologous recombination (HR) to maintain genomic stability.
Key functions include:
DNA Interstrand Crosslink Repair: FANCD2 monoubiquitination is required for ICL repair during S and G2 phases
Homologous Recombination: Facilitates HR repair of double-strand breaks
Research on FANCD2 Gene has revealed important connections between DNA repair mechanisms and neurodegenerative diseases. Studies have shown that variants in DNA repair genes can influence susceptibility to Parkinson's disease and ALS, potentially through effects on mitochondrial function and cellular stress responses.
The protein encoded by this gene plays a role in maintaining genomic stability, and dysregulation may contribute to the accumulation of DNA damage in neurons over time. This has implications for understanding the molecular basis of neurodegeneration and developing therapeutic interventions.
References
[Taniguchi et al., FANCD2 monoubiquitination and the DNA damage response (2002) (2002)](https://doi.org/10.1016/s0092-8674(02)
[Garcia-Higuera et al., FANCD2 and cellular response to DNA damage (2001) (2001)](https://doi.org/10.1016/s0092-8674(01)
[Kelley et al., Fanconi anemia pathway and neurodegeneration (2011) (2011)](https://doi.org/10.1016/j.dnarep.2011.06.004)
[Howlett et al., Biallelic inactivation of FANCD2 in a patient with Fanconi anemia (2005) (2005)](https://doi.org/10.1158/0008-5472.CAN-05-2093)
[Matsumoto et al., FANCD2 functions in DNA repair and neurological disease (2019) (2019)](https://doi.org/10.1093/jnen/nlz037)
Pathway Diagram
The following diagram shows the key molecular relationships involving FANCD2 Gene discovered through SciDEX knowledge graph analysis: